X0306 4 2020-10-01 0 0001370637 ETSY INC ETSY 0001770886 PATEL GOYAL KRUTI C/O ETSY, INC. 117 ADAMS STREET BROOKLYN NY 11201 0 1 0 0 Chief Product Officer Common Stock 2020-10-01 4 M 0 11432 0.00 A 33171 D Common Stock 2020-10-01 4 F 0 6086 131.69 D 27085 D Common Stock 2020-10-01 4 M 0 7330 14.06 A 34415 D Common Stock 2020-10-01 4 M 0 1930 10.23 A 36345 D Common Stock 2020-10-01 4 M 0 669 28.38 A 37014 D Common Stock 2020-10-01 4 S 0 508 123.84 D 36506 D Common Stock 2020-10-01 4 S 0 1135 126.47 D 35371 D Common Stock 2020-10-01 4 S 0 1200 127.54 D 34171 D Common Stock 2020-10-01 4 S 0 1601 129.08 D 32570 D Common Stock 2020-10-01 4 S 0 1206 129.99 D 31364 D Common Stock 2020-10-01 4 S 0 2869 131.07 D 28495 D Common Stock 2020-10-01 4 S 0 1509 132.12 D 26986 D Common Stock 2020-10-01 4 S 0 170 132.685 D 26816 D Restricted Stock Units 2020-10-01 4 M 0 1199 0.00 D Common Stock 1199 2398 D Restricted Stock Units 2020-10-01 4 M 0 4159 0.00 D Common Stock 4159 12478 D Restricted Stock Units 2020-10-01 4 M 0 4051 0.00 D Common Stock 4051 28361 D Restricted Stock units 2020-10-01 4 M 0 2023 0.00 D Common Stock 2023 10115 D Employee Stock Option (Right to Buy) 14.06 2020-10-01 4 M 0 7330 0.00 D 2025-08-31 Common Stock 7330 10293 D Employee Stock Option (Right to Buy) 10.23 2020-10-01 4 M 0 1930 0.00 D 2027-03-14 Common Stock 1930 30405 D Employee Stock Option (Right to Buy) 28.38 2020-10-01 4 M 0 669 0.00 D 2028-03-14 Common Stock 669 52265 D Shares of common stock acquired upon the vesting of restricted stock units. This transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units. These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.82 to $124.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.985 to $126.975, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.26 to $128.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.55 to $129.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.62 to $130.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.68 to $131.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.68 to $132.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Represents restricted stock units which correspond 1-for-1 with common stock. The restricted stock units vest in 16 equal quarterly installments beginning on July 1, 2017, provided the Reporting Person remains continuously employed on each vesting date and has no expiration date. The restricted stock units vest in 8 equal semi-annual installments, beginning on October 1, 2018, provided the Reporting Person remains continuously employed on each vesting date and has no expiration date. The restricted stock units vest in 8 equal semi-annual installments, beginning on October 1, 2020, provided the Reporting Person remains continuously employed on each vesting date and has no expiration date. The restricted stock units vest in 8 equal semi-annual installments, beginning on October 1, 2019, provided the Reporting Person remains continuously employed on each vesting date and has no expiration date. This stock option is fully exercisable. The shares underlying the option exercised in this transaction were fully vested and exercisable. The originally granted options are exercisable in 48 equal monthly installments beginning on April 15, 2017, provided the Reporting Person remains continuously employed on each vesting date. The shares underlying the option exercised in this transaction were fully vested and exercisable. The originally granted options are exercisable in 8 equal semi-annual installments beginning on October 1, 2018, provided the Reporting Person remains continuously employed on each vesting date. /s/ Alla Berenshteyn, as Attorney-in-Fact for Kruti Patel Goyal 2020-10-05